Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Hyperfine, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of HYPR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4237−5
Shares17.8M16.5M−1.25M (−7.0%)
Value$40.2M$13.4M−$26.9M (−66.8%)

New holders (7)

Institutions that held Hyperfine, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to HYPR in Q3 2022
InstitutionSharesValue% of portfolio
Security Benefit Life Insurance Co2,500,000$2.02M0.19%
Citadel Advisors LLC70,059$57.0K0.00%
EP Wealth Advisors, LLC34,725$28.0K0.00%
CWM, LLC10,000$8.00K0.00%
Thompson Siegel & Walmsley LLC5,555$4.00K0.00%
The PNC Financial Services Group, Inc.4,000$3.00K0.00%
Royal Bank of Canada355$00.00%

Sold out (12)

Institutions that held Hyperfine, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of HYPR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Monashee Investment Management LLC1,742,490$3.89M
Bain Capital Public Equity Management II, LLC864,945$1.93M
Opaleye Management Inc.763,075$1.70M
Wellington Management Group LLP268,044$598.0K
Jane Street Group, LLC72,272$161.0K
Goldman Sachs Group Inc20,651$46.0K
Millennium Management LLC18,396$41.0K
Squarepoint Ops LLC13,958$31.0K
Morgan Stanley6,100$14.0K
Penserra Capital Management LLC4,459$9.00K
JPMorgan Chase & Co2,581$6.00K
Curi Capital500$1.00K